<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    12202325
   </pmid>
   <datecreated>
    <year>
     2002
    </year>
    <month>
     08
    </month>
    <day>
     30
    </day>
   </datecreated>
   <datecompleted>
    <year>
     2002
    </year>
    <month>
     09
    </month>
    <day>
     19
    </day>
   </datecompleted>
   <daterevised>
    <year>
     2009
    </year>
    <month>
     11
    </month>
    <day>
     18
    </day>
   </daterevised>
   <article pubmodel="Print">
    <journal>
     <issn issntype="Electronic">
      1468-5833
     </issn>
     <journalissue citedmedium="Internet">
      <volume>
       325
      </volume>
      <issue>
       7362
      </issue>
      <pubdate>
       <year>
        2002
       </year>
       <month>
        Aug
       </month>
       <day>
        31
       </day>
      </pubdate>
     </journalissue>
     <title>
      BMJ (Clinical research ed.)
     </title>
     <isoabbreviation>
      BMJ
     </isoabbreviation>
    </journal>
    <articletitle>
     Local treatments for cutaneous warts: systematic review.
    </articletitle>
    <pagination>
     <medlinepgn>
      461
     </medlinepgn>
    </pagination>
    <abstract>
     <abstracttext label="OBJECTIVE" nlmcategory="OBJECTIVE">
      To assess the evidence for the efficacy of local treatments for cutaneous warts.
     </abstracttext>
     <abstracttext label="METHODS" nlmcategory="METHODS">
      Systematic review of randomised controlled trials.
     </abstracttext>
     <abstracttext label="MAIN OUTCOMES MEASURES" nlmcategory="METHODS">
      Total clearance of warts and adverse effects such as irritation, pain, and blistering.
     </abstracttext>
     <abstracttext label="STUDY SELECTION" nlmcategory="METHODS">
      Randomised controlled trials of any local treatment for uncomplicated cutaneous warts. All published and unpublished material was considered, with no restriction on date or language.
     </abstracttext>
     <abstracttext label="RESULTS" nlmcategory="RESULTS">
      50 included trials provided generally weak evidence because of poor methods and reporting. The best evidence was for topical treatments containing salicylic acid. Data pooled from six placebo controlled trials showed a cure rate of 75% (144 of 191) in cases compared with 48% (89 of 185) in controls (odds ratio 3.91, 95% confidence interval 2.40 to 6.36). Some evidence for the efficacy of contact immunotherapy was provided by two small trials comparing dinitrochlorobenzene with placebo. Evidence for the efficacy of cryotherapy was limited. No consistent evidence was found for the efficacy of intralesional bleomycin, and only limited evidence was found for the efficacy of topical fluorouracil, intralesional interferons, photodynamic therapy, and pulsed dye laser.
     </abstracttext>
     <abstracttext label="CONCLUSIONS" nlmcategory="CONCLUSIONS">
      Reviewed trials of local treatments for cutaneous warts were highly variable in methods and quality, and there was a paucity of evidence from randomised, placebo controlled trials on which to base the rational use of the treatments. There is good evidence that topical treatments containing salicylic acid have a therapeutic effect and some evidence for the efficacy of dinitrochlorobenzene. Less evidence was found for the efficacy of all the other treatments reviewed, including cryotherapy.
     </abstracttext>
    </abstract>
    <affiliation>
     Department of Dermatology, Ipswich Hospital NHS Trust, Ipswich IP4 5PD. sgibbs@fish.co.uk
    </affiliation>
    <authorlist completeyn="Y">
     <author validyn="Y">
      <lastname>
       Gibbs
      </lastname>
      <forename>
       Sam
      </forename>
      <initials>
       S
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Harvey
      </lastname>
      <forename>
       Ian
      </forename>
      <initials>
       I
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Sterling
      </lastname>
      <forename>
       Jane
      </forename>
      <initials>
       J
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Stark
      </lastname>
      <forename>
       Rosemary
      </forename>
      <initials>
       R
      </initials>
     </author>
    </authorlist>
    <language>
     eng
    </language>
    <publicationtypelist>
     <publicationtype>
      Journal Article
     </publicationtype>
     <publicationtype>
      Research Support, Non-U.S. Gov't
     </publicationtype>
     <publicationtype>
      Review
     </publicationtype>
    </publicationtypelist>
   </article>
   <medlinejournalinfo>
    <country>
     England
    </country>
    <medlineta>
     BMJ
    </medlineta>
    <nlmuniqueid>
     8900488
    </nlmuniqueid>
    <issnlinking>
     0959-535X
    </issnlinking>
   </medlinejournalinfo>
   <chemicallist>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Anti-Bacterial Agents
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Antiviral Agents
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Dermatologic Agents
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      11056-06-7
     </registrynumber>
     <nameofsubstance>
      Bleomycin
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      69-72-7
     </registrynumber>
     <nameofsubstance>
      Salicylic Acid
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      9008-11-1
     </registrynumber>
     <nameofsubstance>
      Interferons
     </nameofsubstance>
    </chemical>
   </chemicallist>
   <citationsubset>
    AIM
   </citationsubset>
   <citationsubset>
    IM
   </citationsubset>
   <commentscorrectionslist>
    <commentscorrections reftype="Cites">
     <refsource>
      Dermatologica. 1984;168(4):178-81
     </refsource>
     <pmid version="1">
      6724070
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Br J Ophthalmol. 1998 Aug;82(8):971-3
     </refsource>
     <pmid version="1">
      9828786
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Interferon Res. 1982;2(2):235-43
     </refsource>
     <pmid version="1">
      7119508
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Acta Derm Venereol. 1977;57(5):445-7
     </refsource>
     <pmid version="1">
      73312
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Br J Dermatol. 1995 Mar;132(3):433-6
     </refsource>
     <pmid version="1">
      7718461
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Br J Dermatol. 1994 Dec;131(6):883-6
     </refsource>
     <pmid version="1">
      7857844
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Br J Dermatol. 1976 Jun;94(6):667-79
     </refsource>
     <pmid version="1">
      820365
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Aten Primaria. 1996 Sep 30;18(5):211-6
     </refsource>
     <pmid version="1">
      8963007
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Z Hautkr. 1981 Jan 1;56(1):41-3
     </refsource>
     <pmid version="1">
      7013310
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Clin Exp Dermatol. 1999 May;24(3):154-9
     </refsource>
     <pmid version="1">
      10354167
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      JAMA. 1999 Sep 15;282(11):1054-60
     </refsource>
     <pmid version="1">
      10493204
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Lancet. 2000 Mar 18;355(9208):963-6
     </refsource>
     <pmid version="1">
      10768434
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Am Acad Dermatol. 2000 Aug;43(2 Pt 1):275-80
     </refsource>
     <pmid version="1">
      10906651
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Br J Dermatol. 1975 Jan;92(1):93-6
     </refsource>
     <pmid version="1">
      1098689
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Ugeskr Laeger. 1975 Dec 15;137(51):3036-8
     </refsource>
     <pmid version="1">
      1105922
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Br J Dermatol. 2001 Oct;145(4):554-7
     </refsource>
     <pmid version="1">
      11703280
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Br J Dermatol. 1992 Sep;127(3):262-5
     </refsource>
     <pmid version="1">
      1382540
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Psychosom Med. 1990 Jan-Feb;52(1):109-14
     </refsource>
     <pmid version="1">
      2305019
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Am Acad Dermatol. 1986 Nov;15(5 Pt 1):1002-6
     </refsource>
     <pmid version="1">
      2431013
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Br J Dermatol. 1988 Apr;118(4):537-43
     </refsource>
     <pmid version="1">
      3377974
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Ugeskr Laeger. 1986 Jan 20;148(4):173-4
     </refsource>
     <pmid version="1">
      3513412
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Infect Dis. 1986 Aug;154(2):328-30
     </refsource>
     <pmid version="1">
      3522759
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Clin Exp Dermatol. 1979 Mar;4(1):81-5
     </refsource>
     <pmid version="1">
      376193
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Arch Dermatol. 1986 Mar;122(3):272-7
     </refsource>
     <pmid version="1">
      3954392
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Practitioner. 1971 Aug;207(238):197-204
     </refsource>
     <pmid version="1">
      4935660
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Dermatologica. 1983;167(2):86-9
     </refsource>
     <pmid version="1">
      6195025
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Acta Derm Venereol. 1984;64(2):177-9
     </refsource>
     <pmid version="1">
      6203313
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Br J Dermatol. 1984 Aug;111(2):197-207
     </refsource>
     <pmid version="1">
      6205676
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Am Acad Dermatol. 1989 Jan;20(1):74-6
     </refsource>
     <pmid version="1">
      2643641
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J R Coll Gen Pract. 1988 Jun;38(311):256-8
     </refsource>
     <pmid version="1">
      3255811
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Ann Periodontol. 1997 Mar;2(1):42-63
     </refsource>
     <pmid version="1">
      9151542
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      BMJ. 1998 Jan 3;316(7124):54
     </refsource>
     <pmid version="1">
      9451271
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="CommentIn">
     <refsource>
      BMJ. 2002 Aug 31;325(7362):461
     </refsource>
     <pmid version="1">
      12211227
     </pmid>
    </commentscorrections>
   </commentscorrectionslist>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N">
      Anti-Bacterial Agents
     </descriptorname>
     <qualifiername majortopicyn="N">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Antiviral Agents
     </descriptorname>
     <qualifiername majortopicyn="N">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Bleomycin
     </descriptorname>
     <qualifiername majortopicyn="N">
      administration &amp; dosage
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Cryotherapy
     </descriptorname>
     <qualifiername majortopicyn="N">
      methods
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Dermatologic Agents
     </descriptorname>
     <qualifiername majortopicyn="N">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Immunotherapy
     </descriptorname>
     <qualifiername majortopicyn="N">
      methods
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Interferons
     </descriptorname>
     <qualifiername majortopicyn="N">
      administration &amp; dosage
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Laser Therapy
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Photochemotherapy
     </descriptorname>
     <qualifiername majortopicyn="Y">
      methods
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Randomized Controlled Trials as Topic
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Salicylic Acid
     </descriptorname>
     <qualifiername majortopicyn="N">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Treatment Outcome
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Warts
     </descriptorname>
     <qualifiername majortopicyn="Y">
      therapy
     </qualifiername>
    </meshheading>
   </meshheadinglist>
   <numberofreferences>
    49
   </numberofreferences>
   <otherid source="NLM">
    PMC119440
   </otherid>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      2002
     </year>
     <month>
      8
     </month>
     <day>
      31
     </day>
     <hour>
      10
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      2002
     </year>
     <month>
      9
     </month>
     <day>
      20
     </day>
     <hour>
      10
     </hour>
     <minute>
      1
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      2002
     </year>
     <month>
      8
     </month>
     <day>
      31
     </day>
     <hour>
      10
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="pubmed">
     12202325
    </articleid>
    <articleid idtype="pmc">
     PMC119440
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

